ALPS Advisors’s Astera Labs ALAB Stock Holding History

ALPS Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,002	Closed	-$333K	–	1158
2025 Q4	$333K	Buy	2,002 +12	+0.6%	+$2.01K	﹤0.01%	929
2025 Q3	$390K	Buy	+1,990	New	+$327K	﹤0.01%	923

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

ALPS Advisors's ALAB Position: Q1 2026 in Review

ALPS Advisors sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 2,002 shares — an estimated $333K sold.

ALPS Advisors first reported a position in ALAB in Q3 2025 and held it in 2 quarters. The position peaked at $390K in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

ALPS Advisors reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
ALPS Advisors sold 2,002 Astera Labs shares in Q1 2026, an estimated $333K.
ALPS Advisors first reported a position in Astera Labs in Q3 2025 and held it in 2 quarters.
ALPS Advisors's Astera Labs position peaked at $390K in Q3 2025.
703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.